Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

China continues to be a source of innovation as Pfizer strikes biggest pact yet; HHS provides more info on Trump’s Most ...

Pharmaceutical stocks, including Pfizer (NYSE: PFE) have recently come under scrutiny following President Trump’s executive order directing drugmakers to lower medicine prices to match what ...

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

Pfizer will produce the drug, which targets lung and colorectal cancers, in the US and take a US$100 million stake in China’s ...

President Donald Trump will sign an executive order Monday to link the cost of drugs to prices abroad, under a so-called ...

Pfizer Inc. (NYSE:PFE) announced it had entered into a licensing agreement valued at approximately $6 billion with Chinese ...

The president has long complained that the United States pays more for medicines than other wealthy countries. But he offered ...

U.S. President Donald Trump signed a broad executive order on Monday directing drugmakers to lower the prices of their ...